|
|
|
 |
Marketwired News
Biotech Med BioGene Inc. Comments on Market Activity VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 17, 2013) - Med BioGene Inc. (TSX VENTURE:MBI) today, at the request of the Investment Industry Regulatory Organization of Canada (IIROC), announced that Med BioGene's management is unaware ...(More) National Animal Supplement Council Honors Companies for Excellence in Improving the Standards of the Animal Health Supplement Industry and Presents Ben Jones With Lifetime Achievement Award ST. PETERSBURG, FL--(Marketwired - May 17, 2013) - National Animal Supplement Council (NASC) hosted its 3rd annual awards ceremony on May 16, oceanfront at the TradeWinds Island Grand Resort on St. Pete Beach. Companies were honored for exceptional efforts in their commitment to ...(More) Confirmation of BioSyent Inc. 2013 AGM Location TORONTO, ONTARIO--(Marketwired - May 17, 2013) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today announced that certain documents (the Proxy and the VIF) that have been mailed to shareholders in connection with the 2013 annual general m...(More) Aeolus Strengthens Board of Directors With Oncology, Government Contracting and Financial Industry Veterans MISSION VIEJO, CA--(Marketwired - May 17, 2013) - Aeolus Pharmaceuticals, Inc. ( Galapagos creates new warrant plan MECHELEN, BELGIUM--(Marketwired - May 17, 2013) - Galapagos NV ( DHS Holding, Co. Confirms LuckyFoxCasino.com NASHVILLE, TN--(Marketwired - May 17, 2013) - DHS Holding, Co. ( Immunotec Announces New CEO VAUDREUIL-DORION, QUÉBEC--(Marketwired - May 17, 2013) - Immunotec Inc. (TSX VENTURE:IMM), a Canadian based company and a leader in the wellness industry ("Immunotec" or the "Company"), today announced the appointment of Mr. Charles ...(More) PURE Bioscience Appoints Dave Pfanzelter Chairman of the Board SAN DIEGO, CA--(Marketwired - May 17, 2013) - PURE Bioscience ( PURE Bioscience Stock to Begin Trading on the OTCQB Marketplace SAN DIEGO, CA--(Marketwired - May 17, 2013) - PURE Bioscience ( Novo Nordisk reports positive results from first phase 3 trial with long-acting factor IX for treatment of haemophilia B BAGSVAERD, DENMARK--(Marketwired - May 17, 2013) - Novo Nordisk today announced the completion of paradigm™ 2, the first phase 3 trial with a long-acting FIX derivative, N9-GP (glycopegylated recombinant factor IX), for haemophilia B patients. Paradigm™ 2 is a multi-centre, blinded t...(More) EnteroMedics Completes VBLOC Therapy Pre-PMA Meeting With FDA ST. PAUL, MN--(Marketwired - May 17, 2013) - EnteroMedics Inc. ( Sobi appoints Mats-Olof Wallin as permanent Chief Financial Officer STOCKHOLM, SWEDEN--(Marketwired - May 17, 2013) - Mats-Olof Wallin, who recently took on the role as interim Chief Financial Officer (CFO), has been appointed Senior Vice President and CFO at Swedish Orphan Biovitrum AB (publ.) (Sobi). After a thorough search process supported by a senior Ex...(More) Galapagos business update MECHELEN, BELGIUM--(Marketwired - May 17, 2013) - Galapagos NV (Euronext: GLPG) announced today that the operational and financial results achieved thus far in 2013 encourage the Company to retain full year 2013 Group revenues guidance of EUR160 million. "Galapagos has a maturing and bro...(More) AbbVie and Galapagos extend GLPG0634 collaboration to include Crohn's disease NORTH CHICAGO, IL and MECHELEN, BELGIUM--(Marketwired - May 17, 2013) - * First selective JAK1 inhibitor to enter Phase 2 studies in Crohn's disease * Galapagos to fund and complete Phase 2 study; AbbVie to pay Galapagos $50 million upon successful completion, expected in 2015 ...(More) Prima BioMed Issues the Following Notice to Stockholders of the Company SYDNEY, AUSTRALIA--(Marketwired - May 16, 2013) - Prima BioMed Ltd ( Immunovaccine Announces Financial Results for the Quarter Ended March 31, 2013 HALIFAX, NOVA SCOTIA--(Marketwired - May 16, 2013) - Immunovaccine Inc. ("Immunovaccine" or "IMV") (TSX VENTURE:IMV), a clinical stage vaccine company, today released its financial and operational results for the quarter ended March 31, 2...(More) Rockwell Medical Announces the Exercise of Over-Allotment Option WIXOM, MI--(Marketwired - May 16, 2013) - Rockwell Medical, Inc. ( Paladin Labs to Present at the Bloom Burton & Co. Healthcare Investor Conference in Toronto MONTREAL, CANADA--(Marketwired - May 16, 2013) - Paladin Labs Inc. (TSX:PLB), a leading Canadian specialty pharmaceutical company, announced today that Mr. Mark Beaudet, interim President & CEO is scheduled to present a corporate upda...(More) SciClone Reports Anticipated Financial Results for the First Quarter 2013 FOSTER CITY, CA--(Marketwired - May 16, 2013) - SciClone Pharmaceuticals, Inc. ( Friedhe...(More) SciClone and Zensun Enter Into a Licensing Agreement for Novel Chronic Heart Failure Drug Neucardin(TM) for the China Market FOSTER CITY, CA--(Marketwired - May 16, 2013) - SciClone Pharmaceuticals, Inc. ( Applied DNA Sciences Reports Fiscal Second Quarter 2013 Results STONY BROOK, NY--(Marketwired - May 16, 2013) - Applied DNA Sciences, Inc. ( Peregrine Pharmaceuticals' Immunotherapy Bavituximab to Be Highlighted in Three Clinical Data Presentations at 2013 ASCO Annual Meeting TUSTIN, CA--(Marketwired - May 16, 2013) - Peregrine Pharmaceuticals, Inc. ( Alethia Biotherapeutics Announces the Issuance of a United States Patent for Monoclonal Antibodies Targeting Secreted Clusterin for Inhibition of EMT MONTREAL, QUEBEC--(Marketwired - May 16, 2013) - Alethia Biotherapeutics Inc., a privately held biotechnology company focusing on the development of therapeutic monoclonal antibodies, announced today that the Company has been granted Unit...(More) NewLink Genetics to Be Added to NASDAQ Biotechnology Index AMES, IA--(Marketwired - May 16, 2013) - NewLink Genetics Corporation ( NewLink Genetics to Present Data on Cancer Immunotherapy Programs at the ASCO 2013 Annual Meeting AMES, IA--(Marketwired - May 16, 2013) - NewLink Genetics Corporation ( Stock House Group Report Initiates Coverage on ForeverGreen Worldwide, Corp. NEW YORK, NY--(Marketwired - May 16, 2013) - After careful analysis, Stock House Group, a full service research and content development investor relations firm, has initiated coverage and placed a Speculative Buy Rating on ForeverGreen Worldwide, Corp. ( Silicon Valley Foundry Noel Technologies Adds Advanced Lithography Services CAMPBELL, CA--(Marketwired - May 16, 2013) - Noel Technologies, a Silicon Valley technology foundry offering process development and substrate fabrication, recently expanded its capabilities to include advanced lithography services. To push their technology roadmap to 0.15 micron, they have hire...(More) Stem Cell Therapeutics to Begin Trading on the U.S. OTCQX Marketplace TORONTO, ONTARIO--(Marketwired - May 16, 2013) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS), a biopharmaceutical company developing cancer stem cell-related technologies, today announced that the Company's stock will trade on OTCQX In...(More) Stem Cell Therapeutics Announces Completion of Dosing in Phase I Study of TTI-1612 in Patients With Interstitial Cystitis/Bladder Pain Syndrome TORONTO, ONTARIO--(Marketwired - May 16, 2013) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS), a biopharmaceutical company developing cancer stem cell-related technologies, today announced that its wholly owned subsidia...(More) Pharmaceutical-Biotech Industry to Pull Plug on 30 North American Sites in 2013, an Industrial Info News Alert SUGAR LAND, TX--(Marketwired - May 16, 2013) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- In a case of bad news being not quite as bad as it could be, the More) Vital Therapies, Inc. Adds Two New Board Members SAN DIEGO, CA--(Marketwired - May 16, 2013) - Vital Therapies, Inc., a development stage biotechnology company focused on developing the first bio-artificial liver for life-threatening acute liver failure, today announced the election of Doug Godshall and Lowell Sears to the company's Board of D...(More) DBV Technologies and Stallergenes Enter Into Partnership for the Development of Innovative Treatment of Respiratory Allergies ANTONY, FRANCE and BAGNEUX, FRANCE--(Marketwired - May 16, 2013) - DBV Technologies
( Annual General Meeting of Active Biotech AB LUND, SWEDEN--(Marketwired - May 16, 2013) - The Annual General Meeting of Active Biotech was held on May 15, 2013. In accordance with the Board of Directors' proposal, it was resolved that no dividend would be paid. In accordance with the Election Committee's proposal, the Board ...(More) New data to be presented at the 2013 ASCO Annual Meeting show Active Biotech's commitment to oncology research LUND, SWEDEN--(Marketwired - May 16, 2013) - Active Biotech (NASDAQ OMX NORDIC: ACTI) will present data from two of its oncology projects, the drug candidates tasquinimod for the treatment of prostate cancer and ANYARA for the treatment of renal cell cancer, at the scientific conference "2013 AS...(More) Algeta ASA: New data and analyses from clinical trials of Xofigo(R) (radium Ra 223 dichloride) to be presented at ASCO OSLO, NORWAY--(Marketwired - May 16, 2013) - Intended for US Media only
Algeta ASA ( Pharming reports on financial results first quarter 2013 LEIDEN, NETHERLANDS--(Marketwired - May 16, 2013) - Biotech company Pharming Group NV ("Pharming" or "the Company") (NYSE Euronext: PHARM) today published its financial report for the three months ended 31 March 2013.
* Revenues and other income decre...(More) Titan Pharmaceuticals Announces First Quarter 2013 Financial Results SOUTH SAN FRANCISCO, CA--(Marketwired - May 15, 2013) - Titan Pharmaceuticals, Inc. ( Onyx Pharmaceuticals Announces Data Presentations at 49th American Society of Clinical Oncology Annual Meeting SOUTH SAN FRANCISCO, CA--(Marketwired - May 15, 2013) - Onyx Pharmaceuticals, Inc. ( Jennerex Presents Pexa-Vec Clinical Data at 2013 American Society of Clinical Oncology Annual Meeting CHICAGO, IL--(Marketwired - May 15, 2013) - Jennerex Biotherapeutics, Inc., a private, clinical-stage biotechnology company focused on the development and commercialization of best-in-class targeted oncolytic immunotherapies for solid tumors, today announced that data relating to the company's le...(More) Applied DNA Sciences and SmokeCloak, A/S Launch DNA Fog STONY BROOK, NY--(Marketwired - May 15, 2013) - Applied DNA Sciences, Inc. ( BioExx Announces Q1 2013 Results TORONTO, ONTARIO--(Marketwired - May 15, 2013) - BioExx Specialty Proteins Ltd. (TSX:BXI) today announced its financial results for the three months ended March 31, 2013.<...(More) DARA Reports First Quarter 2013 Financial Results and Operational Highlights
RALEIGH, NC--(Marketwired - May 15, 2013) - DARA BioSciences, Inc. ( Boston Therapeutics Reports First Quarter 2013 Results MANCHESTER, NH--(Marketwired - May 15, 2013) - Boston Therapeutics, Inc. ( Aeolus Pharmaceuticals Announces Second Quarter Fiscal Year 2013 Financial Results MISSION VIEJO, CA--(Marketwired - May 15, 2013) - Aeolus Pharmaceuticals, Inc. ( Jennerex Announces Science Translational Medicine Publication Highlighting Pexa-Vec's Ability to Induce Functional Anti-Cancer Immunity in Patients With Diverse Tumor Types SAN FRANCISCO, CA--(Marketwired - May 15, 2013) - Jennerex Biotherapeutics, Inc., a private, clinical-stage biotechnology company focused on the development and commercialization of best-in-class targeted oncolytic immunotherapies for solid tumors, today announced the publication of data demonst...(More) Algeta Announces That Xofigo(R) (Radium Ra 223 Dichloride) Injection Has Been Approved by the US FDA as Treatment for Castration-Resistant Prostate Cancer With Bone Metastases OSLO, NORWAY--(Marketwired - May 15, 2013) - Intended for US Media only * Algeta to host international conference call scheduled for tomorrow at 08:00 CET, 02:00 Eastern time - details below
Oslo, Norway, 15 May 2013 - Algeta ASA ( SPAARx Celebrates Official Launch at 2013 Armada Specialty Pharmacy Summit in Las Vegas FLORHAM PARK, NJ--(Marketwired - May 15, 2013) - The Specialty Pharmacy Association of America (SPAARx), the largest national association representing the broad interests of the specialty pharmacy industry, celebrated its official launch at the 2013 Annual Armada Specialty Pharmacy Summit i...(More) IsoRay, Inc. Reports Third Quarter Results RICHLAND, WA--(Marketwired - May 15, 2013) - IsoRay, Inc. ( Thermedical Secures $5.5 Million in Series A2 Financing Round WALTHAM, MA--(Marketwired - May 15, 2013) - Thermedical®, a medical equipment company developing new tissue-ablation therapies, announced today that it has completed a $5.5 Million Series A2 Financing Round. Samuel H. Maslak, Sc.D. and Karl H. ...(More) Rapid Micro Biosystems Announces Hands-On Workshops at New European Headquarters in Munich, Germany BEDFORD, MA and FREISING, GERMANY--(Marketwired - May 15, 2013) - Rapid Micro Biosystems, a leading provider of automated, non-destructive, rapid microbial detection, today announced the opening of a state-of-the-art microbiology laboratory and headquarters located in Freising, just outside of M...(More) |
SNS Home
Recent Issues